Reishi Mushroom: What the New Lab Research Adds, and What It Doesn't
- Joyce Knieff, ND, LAc
- 6 days ago
- 7 min read
Reishi mushroom (Ganoderma lucidum) has been on shelves and in tea blends for so long that it might feel like the science around it is settled. It is anything but. A new paper out of Zhejiang Gongshang University in China takes a closer look at what actually happens to the active compounds in reishi when they hit the digestive tract, how those compounds interact with the gut microbiome, and what immune cells do in response. The findings are mechanistically interesting, with one important caveat. This was a laboratory study, not a clinical trial. The implications are more modest than the press releases tend to suggest.
TL;DR: A new lab study found that reishi compounds feed beneficial gut bacteria and calm inflammatory signaling, but this was a cell and digestion model, not a human trial.
Key takeaways:
This was an in vitro study using simulated digestion and a mouse cell line.
Less than 10 percent of reishi's active compounds survive digestion intact.
What survives feeds beneficial gut bacteria and raises anti-inflammatory butyrate.
Human evidence is still small; reishi works best as support, not a primary treatment.
What the research found
The study, led by Tianjia Jiang and a team at Zhejiang Gongshang University and published in Food Research International in early 2026, used an artificial digestion model to simulate what happens when reishi extracts pass through the stomach and small intestine. The researchers tested two extracts side by side: one made with water, the other with ethanol. They then exposed the digested extracts to a mouse macrophage cell line (RAW 264.7) and analyzed gene expression with RNA sequencing.
A few important findings emerged. First, the bioavailability of reishi's active components is low. Less than 10 percent of the bioactive material survives the digestive process intact. This is consistent with what's been suspected clinically for years, that getting therapeutic quantities of reishi compounds into systemic circulation through oral supplementation is harder than the label often suggests.
Second, what does survive interacts meaningfully with the gut microbial community. The research team found that reishi components selectively favored beneficial bacteria and suppressed Megasphaera, a genus often elevated in inflammatory gut states. The downstream effect was an increase in colonic butyrate, a short-chain fatty acid that has direct anti-inflammatory effects on the gut lining and broader immune signaling.
Third, in the macrophage assay, reishi-treated cells produced less of the inflammatory mediators nitric oxide, TNF-alpha, and IL-1 beta. RNA sequencing showed that the gene-expression changes ran through the TH17 and TLR3/IRF7 immune-signaling pathways, with specific genes (Cxcl10, Stat1, Ms4a6d) identified as central players in the anti-inflammatory response.
The main caveat is the design. This was an in vitro study using simulated digestion and a mouse cell line. It tells us something about how reishi compounds interact with biological systems in controlled conditions. It does not tell us what happens in a real human gut, with a real microbiome, in a real body, with real disease states. That work still needs to happen.
Where this fits in the broader picture
The reishi clinical research base is smaller than the cultural footprint of the mushroom would suggest. The most rigorous synthesis to date is a Cochrane systematic review published in 2016 by Jin and colleagues, which evaluated five randomized controlled trials of reishi in cancer patients. The review found that reishi added to conventional chemotherapy or radiation was associated with somewhat better tumor response (RR 1.50, 95% CI 0.90 to 2.51) and modest improvements in immune cell counts (CD3, CD4, CD8) and quality of life. The reviewers concluded that reishi might be reasonable as an adjunct to conventional cancer treatment in some cases, with no significant toxicity reported, but the studies were of variable methodological quality and the evidence was not sufficient to recommend reishi as a primary treatment for any condition.
A smaller randomized trial by Henao and colleagues, published in the International Journal of Medicinal Mushrooms in 2018, gave children aged 3 to 5 in Medellín, Colombia, a yogurt enriched with reishi β-glucans daily for 12 weeks. Children in the reishi arm had higher counts of circulating immune cells (CD3, CD4, CD8 T-cells) than children in the placebo arm. The intervention was well tolerated with no significant adverse events. This is a more modest finding than the headlines often suggest, but it does add a piece to the picture: reishi β-glucans appear to interact with the immune system in measurable ways even in healthy populations.
A 2025 review in Molecules by Szelenberger and Więckowska synthesized the mechanistic evidence on fungal polysaccharides (including reishi β-glucans) and liver health, identifying the same general signaling pathways (NF-κB, Nrf2, NLRP3 inflammasome, gut-microbiota modulation) that the new study identifies. The mechanisms are reasonably well characterized at this point. The clinical implications are still being worked out.
The naturopathic perspective
The reishi story is a useful illustration of where the larger questions about botanical medicine actually sit. The traditional use is long, the mechanistic plausibility is strong, the clinical research base is small but suggestive, and the supplement aisle has long since gotten ahead of where the evidence actually is. Holding all of those pieces at once is the more honest place to stand than either dismissing reishi or treating it as a panacea.
The newer findings on reishi's interaction with the gut microbiome line up with the way naturopathic medicine has often thought about adaptogens and tonics. Many of these substances appear to work less through a single pharmacological pathway and more through a distributed effect on the inflammatory, immune, and microbial environment of the body. The Jiang study identifies one piece of that distributed effect: digested reishi components feed beneficial gut bacteria, which produce butyrate, which calms inflammatory signaling, which shifts immune-cell behavior. The chain runs through the gut.
This frame shapes how reishi is most likely to be helpful clinically. The conditions where the existing evidence is most relevant include chronic inflammatory states (where the anti-inflammatory and gut-microbial effects might support recovery), adjunct support in oncology (where the Cochrane evidence is most developed, but only as a supplement to standard care, never as a replacement), and immune-modulation in stress-related or post-illness states where the system needs gentle support rather than direct stimulation. The conditions where reishi has not been well studied include serious mental health conditions, pregnancy, pediatric use outside the specific β-glucan-yogurt context of the Henao trial, and any condition where it is being marketed as a primary treatment. There is also an interaction concern with blood thinners, immunosuppressants, and certain blood-pressure medications that warrants individualized clinical attention.
A few additional clinical pieces. The reishi product market is highly variable, and standardization is uneven. Quality is the variable to watch: look for products that specify fruiting body source, extraction method (the new study suggests aqueous and ethanol extracts behave differently), and standardization to active compounds like β-glucans or triterpenes. Whole-food powders, hot-water extracts, and dual extracts each have different profiles. A clinician with experience in botanical medicine can help match the product to the goal.
How to apply this now
If you are curious about reishi, a few practical pieces. Quality of product matters more than dose, particularly given the bioavailability concerns the new study highlights. A traditional approach is daily reishi tea, slowly simmered, used as a tonic over months rather than acutely for short-term effects. If supplements are preferred, look for a reputable brand with transparent sourcing and standardization. If you are working with a clinical condition (autoimmune disease, cancer treatment, blood-thinning medication, immunosuppression, organ transplant, pregnancy, or significant cardiovascular disease), please bring the conversation to a clinician who can review your full picture before adding reishi or any other functional mushroom.
The bigger frame is what reishi sits inside. Adaptogens and immune-modulating mushrooms work best in a body that is being supported by the basics. Sleep that actually restores. A nutrient-dense, anti-inflammatory eating pattern. Movement most days. Stress-regulation practices that work for your life. Connection. A meaningful relationship with rest. None of this is glamorous, and none of it can be packaged into a capsule. Reishi can be a useful piece of a fuller plan. It cannot do the work by itself.
Frequently asked questions
Should I try reishi myself?
If you are generally healthy and curious, reishi has a long traditional safety record, and a daily tea used as a tonic is a reasonable place to start. If you take prescription medications or manage a health condition, talk with a clinician first. This new study doesn't change that basic guidance.
How much should I take, and for how long?
There is no well-established therapeutic dose from human trials, and that gap is part of the picture here. Traditionally reishi is used slowly, over months, more as a tonic than a quick fix. Given the low bioavailability this study highlights, product quality probably matters more than chasing a high dose.
Who should avoid reishi?
Reishi can interact with blood thinners, immunosuppressants, and some blood-pressure medications. If you are pregnant, undergoing cancer treatment, managing an autoimmune condition, or have had an organ transplant, don't add it without clinical guidance.
Does this study mean reishi treats a disease?
No. This was a laboratory study using simulated digestion and a mouse cell line. It shows how reishi compounds behave in controlled conditions, not what they do in a human body with a real disease. The strongest human evidence is still a small set of trials, mostly as an adjunct in cancer care.
How does Yggdrasil think about reishi and other functional mushrooms?
We see reishi as one supportive piece of a fuller plan, not a stand-alone treatment. It tends to work best in a body that already has the basics in place: sleep, nourishing food, movement, and stress regulation. A clinician can help match the product and the goal to your situation.
References
Jiang T, Zhu R, Guo X, Li J, Zhu X, Bao R, Chen J. Comprehensive evaluation of Ganoderma lucidum extracts: digestion kinetics, gut microbiota modulation, and immunoregulatory mechanisms. Food Res Int. 2026;230:118664. PMID: 41794511. DOI. Original AANP digest link: https://www.sciencedirect.com/science/article/abs/pii/S0963996926003406
Jin X, Ruiz Beguerie J, Sze DM, Chan GCF. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016;4(4):CD007731. PMID: 27045603. DOI.
Duque Henao SL, Urrego SA, Cano AM, Higuita EA. Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with β-Glucans from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellin, Colombia. Int J Med Mushrooms. 2018;20(8):705-716. PMID: 30317947. DOI.
Szelenberger R, Więckowska M. Fungal Polysaccharides as Modulators of Molecular Pathways in Liver Health. Molecules. 2025;30(22):4384. PMID: 41302443. DOI.
A note before you go
This is for educational purposes and is not a substitute for individualized medical care. Botanical supplements interact with medications and underlying health conditions in ways that warrant a real clinical conversation. If you are considering reishi or any other medicinal mushroom, especially if you have an autoimmune condition, are undergoing cancer treatment, are pregnant or trying to conceive, or take prescription medications, please work with a clinician who can review your full picture.
Related reading
Reviewed by Joyce Knieff, ND, LAc on 2026-06-12.
If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.
Comments